Having used our molecular analysis to distinguish independent primary tumors from metastatic recurrences in the setting of familial EGFR-mutant lung cancer, we turned to a separate cohort of ten apparently sporadic cases with multiple EGFR-mutant lesions. The gene discussed is EGFR; the disease is lung carcinoma.